This should be pretty much the bottom, we are expecting the NT-proBNP approval soon, pehaps this month, Respnse has been getting all it's other approvals - Mioglobin, CK-MB, Troponin I and Flue A and B as well as all the biowarfar agents. Having Roche annouced as a cardiac partner allows them to begin to organize sales channels before NT-proBNP approval so we are good to go as soon as the FDA releases the word. Response has moved into a new facility where the test cartridge production is being set up with the automation necessary to produce large numbers. There may be another financing but we are so close to our goals to being an international enterprise it should be the one that takes over the top. It has been many years to get here you are lucky to be able to purchase shares so close to success.

Best Regards

~~ dimar